NM_013444.4:c.1573C>T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_013444.4(UBQLN2):c.1573C>T(p.Pro525Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000125 in 1,194,329 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 49 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P525A) has been classified as Uncertain significance.
Frequency
Consequence
NM_013444.4 missense
Scores
Clinical Significance
Conservation
Publications
- amyotrophic lateral sclerosis type 15Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 20AN: 112368Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.000334 AC: 49AN: 146519 AF XY: 0.000308 show subpopulations
GnomAD4 exome AF: 0.000119 AC: 129AN: 1081961Hom.: 0 Cov.: 32 AF XY: 0.000139 AC XY: 49AN XY: 352503 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000178 AC: 20AN: 112368Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34514 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Amyotrophic lateral sclerosis type 15 Pathogenic:2Uncertain:2Benign:1
- -
- -
NM_013444.3:c.1573C>T in the UBQLN2 gene has an allele frequency of 0.007 in Ashkenazi Jewish subpopulation in the gnomAD database. The p.Pro525Ser (NM_013444.3:c.1573C>T) variant has been detected in families affected with amyotrophic lateral sclerosis (PMID: 21857683). Functional studies suggest that p.Pro525Ser exhibited intermediate solubility phenotypes compared to wild type (PMID: 29161404). Taken together, we interprete this variant as Pathogenic/Likely pathogenic. ACMG/AMP Criteria applied: PS3; PP4; PM2. -
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
- -
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26944018, 25333069, 26075709, 29161404, 27834214, 28716533, 25398946, 25616961, 26152284, 21857683, 25681989, 34426522, 35047667, 32579787, 30982635, 33891006, 33919255, 31324802, 31942019, 31167121, 32513711, 37039476, 36423739, 35936615, 31319884, 32290710, Durmus2023[Casereport]) -
Amyotrophic lateral sclerosis Benign:1
- -
UBQLN2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at